Metformin may increase Overall Survival in Patients with Resectable Pancreatic Cancer

Theodore S. Hong, MD of Massachusetts General Hospital outlines how Metformin may increase Overall Survival in Patients with Resectable Pancreatic Cancer at ASCO GI 2017.

Metformin may increase Overall Survival in Patients with Resectable Pancreatic Cancer

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Metformin may increase Overall Survival in Patients with Resectable Pancreatic Cancer

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia